Imported-post

Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases. Read More

COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Read More

In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them. Read More

Vitamin D protection against colon cancer varies according to parathyroid hormone response, particularly among women. Read More

An automated system using keyword searches can help identify candidates for clinical trials on adverse drug reactions. Read More

Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging. Read More

One of the largest obstacles for patients seeking effective substance abuse treatment is a lack of transportation to the treatment facilities. Vanderbilt University researcher Janey Camp, associate professor of civil and environmental engineering, is working on a project to help clear those roadblocks. Janey Camp (Vanderbilt University) Camp is leading an 18-month, in-depth analysis of... Read More

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients. Read More

The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances. Read More

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. Read More

This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Read More

Geographically targeted efforts to prevent children being placed in out-of-home care might be possible, Vanderbilt researchers report. Read More

IBM will use a Vanderbilt model as the end-user scripting assistant in its open-source Command Line AI Project. Read More

Vanderbilt researchers demonstrate that the polymer P188 has promise as a therapy to prevent reperfusion injury — the cellular damage that occurs when blood flow returns after an ischemic event like a heart attack. Read More

Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models. Read More

The isolation of human monoclonal antibodies against dangerous viruses including EEEV, Hendra and Nipah could offer new ways to treat and prevent these infections. Read More

COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients. Read More

Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and atherosclerosis. Read More

Discovery provides insight for developing next generation optoelectronic and infrared devices In groundbreaking new research, an international team that includes a Vanderbilt engineer has developed a unique process for producing a quantum state that is part light and part matter. Read More

Anita Mahadevan-Jansen (Vanderbilt University) The Vanderbilt Biophotonics Center, directed by Anita Mahadevan-Jansen, Orrin H. Ingram Professor of Biomedical Engineering, conducts research on clinical photonics, neurophotonics and multiscale photonics to develop optical technologies that improve patient care. When Vanderbilt ramped down in-person research activities in mid-March due to the COVID-19 pandemic, Mahadevan-Jansen and her team did... Read More